Definium Therapeutics Inc. Common Shares vs Hudbay Minerals Inc. Ordinary Shares (Canada) — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.71B), while Hudbay Minerals Inc. Ordinary Shares (Canada) trades at $26.12 (market cap $11.52B). The key difference: Hudbay Minerals Inc. Ordinary Shares (Canada) is far larger — about 2.4× Definium Therapeutics Inc. Common Shares's market cap, and Hudbay Minerals Inc. Ordinary Shares (Canada) pays a 0.11% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Hudbay Minerals Inc. Ordinary Shares (Canada) for 0 Days on average.
| DFTX | HBM | |
|---|---|---|
Market Cap | $4.71B | $11.52B |
Volume | 1,966,636 | 4,227,671 |
Sector | Health | Basic Materials |
52-Week High | $48.45 | $31.87 |
52-Week Low | $10.68 | $14.58 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $11.58B |
Dividend Yield | — | 0.11% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Hudbay Minerals is a mining company producing copper, gold, zinc, and other metals. Its operations are located in the Americas.
Read more on HBM →